STRATA Skin Sciences Reports Third Quarter 2020 Financial Results
HORSHAM, Pa. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
STRATA Skin Sciences to Present at Three Upcoming Investor Conferences
HORSHAM, Pa. , Nov. 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
STRATA Skin Sciences to Report Third Quarter 2020 Financial Results on November 10, 2020
HORSHAM, Pa. , Nov. 03, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences’ XTRAC® Technology Found to Be Most Effective and Most Economical Treatment for Plaque Psoriasis Compared to Other Therapies
Delivers fastest results with fewest adverse events compared to topical, traditional UV, biologic and systemic therapies Providing a better solution for I ntegrated H ealth S ystems and Capitation healthcare – managing the patients and reducing costs for chronic skin disease Up to 97% savings
STRATA Skin Sciences Announces: Expanding Medical Coverage for Excimer Laser Treatment of Dermatological Conditions, Enlarging Company’s Addressable Market
Cigna Now Provides Insurance Coverage of Excimer Laser Therapy for the treatment of Vitiligo HORSHAM, Pa. , Oct. 19, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing,
STRATA Skin Sciences to Participate in the MicroCap Rodeo Best Ideas Bowl
HORSHAM, PA / ACCESSWIRE / October 6, 2020 / STRATA Skin Sciences (NASDAQ:SSKN) ("STRATA") a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that
STRATA Skin Sciences Announces New Recurring Revenue Direct Distribution Contract with JMEC Co., Ltd. in Japan
Company expanding global presence and introducing recurring business model in Japan HORSHAM, Pa. , Sept. 14, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and
STRATA Skin Sciences to Present at Two Upcoming Investor Conferences
HORSHAM, Penn. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today
STRATA Skin Sciences Reports Second Quarter 2020 Financial Results
Recurring revenue for the second quarter of 2020 was $2.8 million , a 52.1% decrease over second quarter 2019 Total gross margins in the second quarter of 2020 was 48.7%, a 14.9% decrease over second quarter 2019 Global recurring revenue installed base totaled 806 systems at June 30, 2020
STRATA Skin Sciences to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 11
HORSHAM, Pa. , Aug. 04, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic